Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. (Q40590332)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

title

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

author name string

C Imai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

K Mihara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

M Andreansky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

I C Nicholson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

C-H Pui

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

D Campana

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

page(s)

676-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

23 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403302

23 November 2019

exact match

0 references

cites work

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Childhood acute lymphoblastic leukaemia--current status and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

The graft-versus-leukemia effects of allogeneic cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Haematopoietic cell transplantation as immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Development and application of receptor-modified T lymphocytes for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

T-cell-receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Structure, function, and serology of the T-cell antigen receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Tumour rejection by gene transfer of 4-1BB ligand into a CD80(+) murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Establishment and characterization of a human histiocytic lymphoma cell line (U-937)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Signals mediated by FcgammaRIIA suppress the growth of B-lineage acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Synthetic activation of caspases: artificial death switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Donor leukocyte infusions for recurrent hematologic malignancies after allogeneic bone marrow transplantation: impact of infused and residual donor T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Immunophenotyping of leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Costimulatory approaches to adoptive immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Costimulation of human CD28- T cells by 4-1BB ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403302

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14961035%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 November 2019

0 references

1 reference